Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending November 30, 2024 (Week 48)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 11,109 35,832 1,276,932 1,535,159
New England 536 1,111 42,956 50,249
Connecticut 94 296 8,723 12,256
Maine 31 81 2,455 2,751
Massachusetts 329 625 24,574 26,827
New Hampshire - 73 2,154 2,597
Rhode Island 65 389 3,924 4,604
Vermont 17 33 1,126 1,214
Middle Atlantic 1,701 4,244 167,739 185,941
New Jersey - 748 29,210 33,225
New York (excluding New York City) 602 930 35,878 39,475
New York City 521 1,507 55,181 62,420
Pennsylvania 578 1,167 47,470 50,821
East North Central 1,150 4,459 160,932 210,551
Illinois 28 1,438 40,104 65,089
Indiana 308 723 28,837 31,659
Michigan 80 876 26,382 39,718
Ohio 484 1,153 45,111 50,852
Wisconsin 250 517 20,498 23,233
West North Central 481 1,987 79,869 90,625
Iowa 68 283 10,889 12,812
Kansas 90 288 10,588 12,449
Minnesota 54 486 18,034 20,241
Missouri 241 648 26,660 28,706
Nebraska - 208 7,217 8,601
North Dakota 28 87 2,796 3,219
South Dakota - 108 3,685 4,597
South Atlantic 3,432 12,281 306,615 352,917
Delaware - 151 4,659 5,269
District of Columbia 49 178 6,237 7,826
Florida 1,216 6,933 98,514 104,244
Georgia 531 1,476 48,364 67,499
Maryland 482 957 28,763 33,329
North Carolina 1 1,437 50,163 61,609
South Carolina 485 1,732 31,549 30,687
Virginia 662 911 34,672 38,372
West Virginia 6 103 3,694 4,082
East South Central 642 2,748 55,613 99,175
Alabama 374 884 28,688 31,056
Kentucky 231 592 14,967 15,706
Mississippi 37 1,006 11,958 18,090
Tennessee - 796 - 34,323
West South Central 424 4,647 179,854 208,834
Arkansas 101 399 14,670 16,649
Louisiana 224 750 31,065 33,810
Oklahoma 16 407 10,009 18,226
Texas 83 3,263 124,110 140,149
Mountain 1,044 2,431 95,352 107,864
Arizona 266 846 34,007 38,292
Colorado 399 747 22,164 23,847
Idaho 48 124 4,681 5,377
Montana 19 90 3,056 3,420
Nevada 125 344 13,282 14,630
New Mexico 59 229 8,029 10,317
Utah 128 239 9,212 10,270
Wyoming - 47 921 1,711
Pacific 1,699 4,838 188,002 229,003
Alaska 47 125 4,326 4,746
California 1,189 3,801 154,056 178,158
Hawaii - 115 - 5,872
Oregon 226 354 12,888 14,240
Washington 237 562 16,732 25,987
U.S. Territories - 113 667 4,854
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 113 667 4,854
U.S. Virgin Islands - 0 - -
Non-U.S. Residents 1 4 50 48
Total 11,110 35,877 1,277,649 1,540,061
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.